Derm Topics

Going In-Depth on Pigmentary Disorders: Dr. Pearl Grimes on Why PDE is a Must-Attend Conference
Pigmentary Disorders Exchange (PDE) SymposiumFor dermatology clinicians, staying at the forefront of therapeutic advances is essential, especially when it comes to conditions that carry profound psychosocial burdens for patients. Few areas in dermatology are evolving as rapidly, or demand as much clinical nuance, as the study and treatment of pigmentary disorders. To dive deeper into these complexities, our friends at Practical Dermatology …
Pigmentary Disorders Exchange (PDE) Symposium
From the ODAC Poster Hall | Imaging and Diagnostic Discordance in Inpatient Dermatology
scientific poster on The Impact of Imaging on Diagnostic Discordance in Inpatient DermatologyImaging is a mainstay of inpatient diagnostics. X-ray, MRI and CT scans are used to diagnose everything from broken bones to cancer. Yet these same imaging modalities are often ordered by hospitalists to diagnose dermatologic conditions even though the findings aren’t typically helpful in making an accurate diagnosis. These unnecessary tests are costly, delay an accurate diagnosis, and can add e …
scientific poster on The Impact of Imaging on Diagnostic Discordance in Inpatient Dermatology
Clindamycin phosphate 1.2% / Adapalene 0.15% / Benzoyl peroxide 3.1% Therapeutic Cheat Sheet
Cabtreo triple combination acne treatmentCabtreo is the first FDA-approved fixed-dose triple-combination topical treatment for acne vulgaris, pairing a lincosamide antibiotic (clindamycin), a synthetic retinoid (adapalene), and a keratolytic oxidizing agent (benzoyl peroxide) into a single once-daily gel. This formulation targets several pillars of acne pathogenesis simultaneously: cutaneous C. acnes proliferation, abnormal keratinizatio …
Cabtreo triple combination acne treatment
Bridging the Gaps: Exploring the Links Between Prurigo Nodularis and Chronic Itch
image of a skin of color male with prurigo nodularis (PN) on his backPrurigo nodularis (PN) is far more than just a persistent itch—it is a distinct, neuroimmune-driven disease entity that demands its own targeted diagnostic and therapeutic roadmap. During a standout session at this year's Skin of Color Update in New York City, Dr. Raj Chovatiya challenged the long-held notion that PN is merely a variant of atopic dermatitis. For patients with skin of color, wher …
image of a skin of color male with prurigo nodularis (PN) on his back
GLP-1 Agonists and Other Approaches to Address Comorbidities in Psoriasis
A picture of Dr. Soung during her interview on GLP-1 agonists and psoriasis comorbiditiesIt’s time for dermatology clinicians to rethink their understanding of obesity and their approach in addressing weight with psoriasis patients. That’s according to Dr. Jennifer Soung, associate professor at Harbor-UCLA Medical Center. Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Soung, who shares a comprehensive perspective in addressing psoriatic arthritis an …
A picture of Dr. Soung during her interview on GLP-1 agonists and psoriasis comorbidities